Bridgewater Associates’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.92M	Sell	134,277 -146,291	-52%	-$2.83M	0.01%	567
2025 Q4	$6.04M	Sell	280,568 -71,707	-20%	-$1.51M	0.02%	477
2025 Q3	$6.79M	Buy	+352,275	New	+$6.28M	0.03%	419
2025 Q2	–	Sell	-19,820	Closed	-$1.26M	–	716
2025 Q1	$1.26M	Buy	19,820 +14,575	+278%	+$1.53M	0.01%	500
2024 Q4	$638K	Buy	+5,245	New	+$643K	﹤0.01%	555
2024 Q2	–	Sell	-23,222	Closed	-$3.01M	–	933
2024 Q1	$3.01M	Sell	23,222 -3,166	-12%	-$388K	0.02%	440
2023 Q4	$2.54M	Sell	26,388 -24,076	-48%	-$2.31M	0.01%	480
2023 Q3	$6.12M	Buy	50,464 +19,608	+64%	+$2.22M	0.04%	316
2023 Q2	$3.53M	Buy	30,856 +386	+1%	+$49.8K	0.02%	371
2023 Q1	$4.2M	Sell	30,470 -27,465	-47%	-$3.56M	0.03%	344
2022 Q4	$7.51M	Sell	57,935 -40,473	-41%	-$4.69M	0.04%	287
2022 Q3	$10.9M	Sell	98,408 -27,110	-22%	-$2.73M	0.06%	243
2022 Q2	$9.41M	Buy	125,518 +121,144	+2,770%	+$8.91M	0.04%	344
2022 Q1	$342K	Buy	+4,374	New	+$335K	﹤0.01%	927
2021 Q3	–	Sell	-3,838	Closed	-$298K	–	788
2021 Q2	$298K	Sell	3,838 -370	-9%	-$28.1K	﹤0.01%	685
2021 Q1	$314K	Buy	+4,208	New	+$388K	﹤0.01%	414